This is a founder-relationship dossier, not a deal dossier: Damyan Nikolov is a Pomona '04 alum and repeat operator who bootstrapped a clinical-skincare brand to 750–800 med-spa accounts on $12K of capital, exited December 2025, transitioned out April 2026, and is now in Bay-Area exploration mode — pre-idea, actively seeking a technical co-founder. His signal is commercial: an inside-sales engine with reps reportedly acquiring clinics at 6–10x industry average, ~80% gross margins, and payback inside 6–9 months per rep. His gap is technical: he has stated explicitly that he needs a CTO-type partner to build in AI-enabled services or hardware, categories where his own founder-market fit has not yet been established.
There is no round, no product, no thesis-defined problem. StoryHouse's engagement here is relationship-building and matchmaking: a first meeting with MJE around potential fit for Edulis (2026-07-07) plus Miles's earlier scoping call (2026-06-14). SH context: no capital request, no fund allocation yet; Damyan is being tracked, invited to events, and paired with select Claremont technical founders. Recommended posture is medium engagement now, with a revisit trigger once he converges on a wedge and pairs with a technical co-founder.
Damyan's stated sector interests — AI-enabled service businesses and hardware — sit inside the fastest-growing lanes in venture in 2026 (Web), which is both an opportunity and a red flag: he risks entering the most-crowded, most-hyped categories without a differentiated wedge. His durable proof-of-execution is in the clinic-distribution channel, itself a $15B med-spa + dermatology market (Web) where consolidation is active but not obviously venture-scale.
| Player | Positioning | Funding / Stage | Edge vs. them |
|---|---|---|---|
| Damyan Newco | Undefined; commercial operator seeking technical co-founder | Pre-idea, pre-round | — |
| Solo technical founders in AI services | Product-led, technical-first go-to-market | Pre-seed / seed abundance (Web) | Damyan has commercial execution most technical founders lack |
| Vertical-AI operator studios | South Park Commons, Neo, Founders Inc. | Institutional (Web) | Studios provide idea-generation Damyan currently lacks; he'd benefit from joining rather than competing |
| Repeat-founder acqui-hire targets | Prior consumer/DTC operators pivoting to AI | Ubiquitous (Web) | Common category; Damyan's clinic-distribution record is more differentiated than most |
Moat: None yet. His durable edge is a repeatable field-sales-and-recruiting playbook honed in a hard-to-crack channel, which will only become a moat once paired with a defensible product built by a technical co-founder.
No traction to report — there is no newco, no product, and no customer pipeline. Damyan is ~2 months post-exit and in exploration mode. The relevant traction is the prior company's operating record captured in Company Snapshot above (750–800 clinics, ~80% GM, bootstrapped exit).
Exit-path modeling is premature. His prior lane (clinical skincare / med-spa) trades in 3–8x EBITDA bands for sub-$20M-revenue platforms (Web); a repeat there would not be venture-scale. A venture-scale outcome depends on the AI-services or hardware wedge he has not yet chosen and the technical co-founder he has not yet found. Return math is unmodelable until both are locked.
First direct meeting between MJE and Damyan, initiated by Miles to test fit for Edulis and to seed relations for whatever Damyan builds next. Verdict: unlikely operational fit for Edulis (too expensive, no direct hair-color depth), but a useful mutual introduction.
Miles's discovery call framing Damyan as a repeat operator open to founding or joining an early-stage team. High-quality commercial founder, but pre-idea, still forming conviction, and explicitly seeking technical talent.